Neglected Tropical Diseases Drugs and Vaccines Market : Analysis and Research Re

Posted by Rohini Chaudhari on June 26th, 2019

Global Neglected Tropical Diseases Drugs and Vaccines Market: Overview

Pertinent issues like sanitation, cleanliness, and hygiene still worry several parts of the world even today. This results in spike of infections and diseases that more often than not, get neglected. They are termed as neglected tropical diseases. World Health Organization claims that these disease affect nearly 1 billion people across the globe. This explains the potential for companies in the global neglected tropical diseases drugs and vaccines market. Over the years, the market for drugs and vaccines for neglected tropical diseases has garnered weight which can be attributed to the rising measures taken by WHO and members of the United Nations to reduce disease burden.

Report Overview @ https://www.transparencymarketresearch.com/neglected-tropical-diseases-drugs-and-vaccines-market.html

An upcoming report on the global neglected tropical diseases drugs and vaccines market by Transparency Market Research promises to provide every minute detail pertinent for scaling business in the coming years. It covers the existing trends, challenges, opportunities, key developments, geographical analysis, and competitive landscape.

Global Neglected Tropical Diseases Drugs and Vaccines Market: Notable Developments

Inundated with infections and diseases, the number of notable developments in the global neglected tropical diseases drugs and vaccines market is exhaustive. Some the prominent developments that could aid growth in the coming years include

• Takeda’s vaccine for dengue, Dengvaxia, is expected to hit the market by 2020. This will instill competition among players. Further, vaccine for Zika virus in\s under clinical trial phase II or III.
• In 2017, the World Health Organization (WHO) decided to add new diseases like deep mycoses, snakebites, chromoblastomycosis, and other ectoparasites. The development came after WHO received proposals from different stakeholders to include them in the list of neglected tropical diseases.
• During Global Partners Meeting in April 2017, many players of the global NTD drugs and vaccines market along with philanthropists, and governments decided to pump in US0 million in the next 5 to 7 years to eliminate NTDs.
• At least nine leading pharmaceutical companies, the WHO, technprenuer and philanthropist Bill Gates, and several political leaders across the world came together to sign the London Declaration. The agreement vows to raise funds to eradicate at least 10 out of the 17 targeted NTDs.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65507

Besides these collective efforts, most players in the global market for NTD drugs and vaccines are investing in research and development to launch new drugs for the targeted diseases. Some of the leading brands in the global neglected tropical diseases drugs and vaccines market are GSK, Merck, and Takeda.